StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

Stock analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a note issued to investors on Monday. The firm set a “hold” rating on the stock.

Milestone Scientific Trading Up 1.9 %

Shares of NYSE MLSS opened at $0.95 on Monday. The firm has a market capitalization of $74.00 million, a price-to-earnings ratio of -13.57 and a beta of 1.41. Milestone Scientific has a one year low of $0.54 and a one year high of $1.39. The business has a fifty day simple moving average of $1.09 and a 200 day simple moving average of $0.96.

Institutional Investors Weigh In On Milestone Scientific

Several large investors have recently modified their holdings of MLSS. Geode Capital Management LLC raised its stake in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares in the last quarter. Carnegie Investment Counsel lifted its holdings in Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares during the last quarter. Renaissance Technologies LLC grew its stake in Milestone Scientific by 72.8% during the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after buying an additional 53,198 shares during the last quarter. World Investment Advisors LLC bought a new position in shares of Milestone Scientific in the third quarter valued at approximately $91,000. Finally, Y Intercept Hong Kong Ltd acquired a new position in shares of Milestone Scientific in the 3rd quarter worth approximately $48,000. 5.79% of the stock is currently owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.